Principal Associate Scientist
Tyler Fenske is a Principal Associate Scientist in the Immunotherapy group at ElevateBio. He is responsible for the development of translational assays for various immunotherapy programs, while also contributing to the advancement of second generation product candidates. Tyler brings a wealth of experience in assay design and optimization in the infectious disease and immuno-oncology spaces, for products ranging from preclinical research to commercialization. Previously, Tyler was a researcher at Genocea Biosciences, where he was instrumental in developing assays to characterize vaccine products and generate vital immune monitoring data for advancement of a clinical stage HSV-2 vaccine and an early stage neoantigen immunotherapy. Prior to Genocea, Tyler was an analyst at Emergent BioSolutions, establishing bioassays to define a new manufacturing process for BioThrax®, while also contributing to the development of next generation anthrax vaccines.
Tyler received his B.S. in Biochemistry and Molecular Biology/Biotechnology from Michigan State University.